Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Propranolol for the treatment of vascular sarcomas.
Wagner MJ, Cranmer LD, Loggers ET, Pollack SM. Wagner MJ, et al. Among authors: cranmer ld. J Exp Pharmacol. 2018 Sep 6;10:51-58. doi: 10.2147/JEP.S146211. eCollection 2018. J Exp Pharmacol. 2018. PMID: 30233257 Free PMC article. Review.
Targeting gastrointestinal stromal tumors: the role of regorafenib.
Schroeder B, Li Z, Cranmer LD, Jones RL, Pollack SM. Schroeder B, et al. Among authors: cranmer ld. Onco Targets Ther. 2016 May 20;9:3009-16. doi: 10.2147/OTT.S104081. eCollection 2016. Onco Targets Ther. 2016. PMID: 27284251 Free PMC article. Review.
Pazopanib in the management of advanced soft tissue sarcomas.
Cranmer LD, Loggers ET, Pollack SM. Cranmer LD, et al. Ther Clin Risk Manag. 2016 Jun 9;12:941-55. doi: 10.2147/TCRM.S84792. eCollection 2016. Ther Clin Risk Manag. 2016. PMID: 27354810 Free PMC article. Review.
T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM, He Q, Yearley JH, Emerson R, Vignali M, Zhang Y, Redman MW, Baker KK, Cooper S, Donahue B, Loggers ET, Cranmer LD, Spraker MB, Seo YD, Pillarisetty VG, Ricciotti RW, Hoch BL, McClanahan TK, Murphy E, Blumenschein WM, Townson SM, Benzeno S, Riddell SR, Jones RL. Pollack SM, et al. Among authors: cranmer ld. Cancer. 2017 Sep 1;123(17):3291-3304. doi: 10.1002/cncr.30726. Epub 2017 May 2. Cancer. 2017. PMID: 28463396 Free PMC article.
Response to PD1 inhibition in conventional chondrosarcoma.
Wagner MJ, Ricciotti RW, Mantilla J, Loggers ET, Pollack SM, Cranmer LD. Wagner MJ, et al. Among authors: cranmer ld. J Immunother Cancer. 2018 Sep 25;6(1):94. doi: 10.1186/s40425-018-0413-z. J Immunother Cancer. 2018. PMID: 30253794 Free PMC article.
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial.
Zhang S, Kohli K, Black RG, Yao L, Spadinger SM, He Q, Pillarisetty VG, Cranmer LD, Van Tine BA, Yee C, Pierce RH, Riddell SR, Jones RL, Pollack SM. Zhang S, et al. Among authors: cranmer ld. Cancer Immunol Res. 2019 Aug;7(8):1237-1243. doi: 10.1158/2326-6066.CIR-18-0940. Epub 2019 Jun 6. Cancer Immunol Res. 2019. PMID: 31171504 Free PMC article.
Long-term Outcomes for Extraskeletal Myxoid Chondrosarcoma: A SEER Database Analysis.
Wagner MJ, Chau B, Loggers ET, Pollack SM, Kim TS, Kim EY, Thompson MJ, Harwood JL, Cranmer LD. Wagner MJ, et al. Among authors: cranmer ld. Cancer Epidemiol Biomarkers Prev. 2020 Nov;29(11):2351-2357. doi: 10.1158/1055-9965.EPI-20-0447. Epub 2020 Aug 20. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 32856598
Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical Trial.
Pollack SM, Redman MW, Baker KK, Wagner MJ, Schroeder BA, Loggers ET, Trieselmann K, Copeland VC, Zhang S, Black G, McDonnell S, Gregory J, Johnson R, Moore R, Jones RL, Cranmer LD. Pollack SM, et al. Among authors: cranmer ld. JAMA Oncol. 2020 Nov 1;6(11):1778-1782. doi: 10.1001/jamaoncol.2020.3689. JAMA Oncol. 2020. PMID: 32910151 Free PMC article. Clinical Trial.
95 results